This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Pause and Refresh: Rethinking Coca-Cola's Response to the Georgia Voting Reform Law - Teaching note
Whitler, Kimberly A.; Soltis, SteveTeaching Note DARDEN-M-1020TN-EMarketingTeaching note for product M-1020Starting at €0.00
-
Pause and Refresh: Rethinking Coca-Cola's Response to the Georgia Voting Reform Law
Whitler, Kimberly A.; Soltis, SteveExercise DARDEN-M-1020-EMarketingThis exercise is designed to give students an opportunity to develop a communications plan and press statement for The Coca-Cola Company (Coke) as it attempts to navigate the 2021 Georgia voting law controversy. Specifically, it asks students to assume the role of chief marketing and communications officer (CMCO) at Coke and recommend a communications plan, including a press statement, to fulfill their role as CMCO while living up to the brand’s ...Starting at €8.20
-
Organization and Strategy at Millennium (A)
Wulf, Julie M.; Waggoner, ScottCase HBS-710415-ELeadership and People ManagementThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder and CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to ju...Starting at €8.20
-
Organization and Strategy at Millennium (B)
Wulf, Julie M.; Waggoner, ScottCase HBS-710418-EStrategyThis case examines Millennium's strategic and organizational responses to the rapid evolution of the biopharmaceutical industry. In the early 2000s, as Millennium's competitive advantage in early-stage research slipped away and its losses mounted, founder CEO Mark Levin moved the firm downstream away from research and towards drug development and commercialization, while narrowing horizontal breadth from over a dozen therapeutic classes to just t...Starting at €5.74
-
Corporate Strategy at Berkshire Partners
Wulf, Julie M.; Waggoner, ScottCase HBS-710414-EStrategyThe managing directors of Berkshire Partners, a mid-sized private equity firm, address strategic and organizational challenges in response to turbulent market conditions, rapid firm growth, and the transition of leadership from its founding partners to the next generations. To address some of these dynamics, and to protect Berkshire's corporate advantage, the managing directors established three executive oversight committees, developed new speci...Starting at €8.20
-
Corteva Agriscience: Seeding a New Company (B)
West, June A.; Simko, Paul J.; Maiden, Stephen E.; Soltis, SteveCase DARDEN-BC-0296This case, a follow-up to “Corteva Agriscience: Seeding a New Company (A)” (UVA-BC-0295), provides an epilogue to the story of Jim Collins, CEO of Corteva Agriscience (Corteva), and a look at the ongoing strengths of the company he had helped to build.Starting at €5.74
-
Corteva Agriscience: Seeding a New Company (A)
West, June A.; Simko, Paul J.; Maiden, Stephen E.; Soltis, SteveCase DARDEN-BC-0295This case introduces Corteva Agriscience (Corteva) and its CEO, Jim Collins. Corteva was the corporate offspring of a 2015 merger between Dow and DuPont, two of the world’s largest chemical companies. It was created to be the agriculture business that tieStarting at €8.20